# wombat urls ß PLOS ONE: Sickle Erythrocytes Target Cytotoxics to Hypoxic Tumor Microvessels and Potentiate a Tumoricidal Response
Advertisement
Research Article

Sickle Erythrocytes Target Cytotoxics to Hypoxic Tumor Microvessels and Potentiate a Tumoricidal Response

  • David S. Terman equal contributor mail,

    equal contributor Contributed equally to this work with: David S. Terman, Benjamin L. Viglianti

    dst@sbcglobal.net (DST); mark.dewhirst@duke.edu (MWD)

    Affiliation: Molecular Genetics Program, Jenomic, Carmel, California, United States of America

    These authors also contributed equally to this work.

    X
  • Benjamin L. Viglianti equal contributor,

    equal contributor Contributed equally to this work with: David S. Terman, Benjamin L. Viglianti

    Affiliation: Department of Radiology, University of Michigan, Ann Arbor, Michigan, United States of America

    X
  • Rahima Zennadi,

    Affiliation: Department of Medicine, Division of Hematology, Duke University Medical Center, Durham, North Carolina, United States of America

    X
  • Diane Fels,

    Affiliation: Department of Radiation Oncology, Duke University Medical Center, Durham, North Carolina, United States of America

    X
  • Richard J. Boruta,

    Affiliation: Department of Pediatrics, University of North Carolina, Chapel Hill, North Carolina, United States of America

    X
  • Hong Yuan,

    Affiliation: Department of Radiology, University of North Carolina, Chapel Hill, North Carolina, United States of America

    X
  • Mathew R. Dreher,

    Affiliation: National Institutes of Health, Clinical Center, Diagnostic Radiology Department, Bethesda, Maryland, United States of America

    X
  • Gerald Grant,

    Affiliation: Department of Surgery, Division of Neurosurgery, Duke University Medical Center, Durham, North Carolina, United States of America

    X
  • Zahid N. Rabbani,

    Affiliation: Department of Radiation Oncology, Duke University Medical Center, Durham, North Carolina, United States of America

    X
  • Ejung Moon,

    Affiliation: Department of Radiation Oncology, Duke University Medical Center, Durham, North Carolina, United States of America

    X
  • Lan Lan,

    Affiliation: Department of Biostatistics, Duke University Medical Center, Durham, North Carolina, United States of America

    X
  • Joseph Eble,

    Affiliation: Department of Radiology, Mayo Clinic Foundation, Rochester, Minnesota, United States of America

    X
  • Yiting Cao,

    Affiliation: Department of Surgery, Division of Neurooncology, Duke University Medical Center, Durham, North Carolina, United States of America

    X
  • Brian Sorg,

    Affiliation: Cancer Diagnosis Program, National Cancer Institute, Bethesda, Maryland, United States of America

    X
  • Kathleen Ashcraft,

    Affiliation: Department of Radiation Oncology, Duke University Medical Center, Durham, North Carolina, United States of America

    X
  • Greg Palmer,

    Affiliation: Department of Radiation Oncology, Duke University Medical Center, Durham, North Carolina, United States of America

    X
  • Marilyn J. Telen,

    Affiliation: Department of Medicine, Division of Hematology, Duke University Medical Center, Durham, North Carolina, United States of America

    X
  • Mark W. Dewhirst mail

    dst@sbcglobal.net (DST); mark.dewhirst@duke.edu (MWD)

    Affiliation: Department of Radiation Oncology, Duke University Medical Center, Durham, North Carolina, United States of America

    These authors also contributed equally to this work.

    X
  • Published: January 09, 2013
  • DOI: 10.1371/journal.pone.0052543

Reader Comments (2)

Post a new comment on this article